Incubated by TVM Capital Healthcare, IV ONE marks a significant milestone in the delivery of infusion therapy for patients with chronic illnesses, autoimmune disorders, and nutrient deficiencies in the Kingdom and GCC region. By enhancing access to IV treatments and focusing on a high quality, personalized experience, the center will help reduce patient time to service, increase medication adherence, and support positive clinical outcomes.
The IV One team is comprised of highly skilled and certified infusion nurses, pharmacists, and physicians, as well as administrative professionals with decades of experience in healthcare management and service delivery. IV One strictly adheres to Ministry of Health (MOH) and Saudi Food and Drug Authority (SFDA) regulations and implements rigorous internal protocols to ensure the highest level of patient care and community health.
| Launch date | October 2024 – Read the Announcement |
| Website | https://ivonehealth.com/ |
| Sector | Specialty Clinics and Longterm Care |
| Region | KSA |
| Investment type | Growth |
Investment Rationale
The center represents another example of TVM Capital Healthcare pioneering a new healthcare vertical that previously did not exist. As the first of its kind in Saudi Arabia, IV One is positioned to become the Kingdom’s premier referral hub for outpatient infusion therapy. The center’s technology-enabled operations ensure quality and efficiency through innovative processes that redefine the patient care experience. With a fully integrated health information system, patients and physicians can expect seamless communication with clinical experts throughout the entire care journey, from referral to post-treatment care. This results in better health outcomes and a higher quality of life, through improved management of patients’ long-term treatment needs in a way that minimizes disruption to their daily lives.
Impact
AccessQuality
InnovationFuture Growth Prospects |
   |